General Practice Doctors in St Louis Park, MN Accepting Medicare

3 General Practice doctors found. Showing 1 - 3

Dr. Joseph Judah Greenberg, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 5115 Excelsior Blvd Ste 712, St Louis Park, MN 55416 Phone: 702-964-1525

Carol Manning Iii, General Practice Medicare: Not Enrolled in Medicare Practice Location: 3850 Park Nicollet Blvd, St Louis Park, MN 55416 Phone: 952-993-3025

Andre Montoya Barthelemy, MD General Practice Medicare: Medicare Enrolled Practice Location: 1665 Utica Ave S Ste 100, St Louis Park, MN 55416 Phone: 952-541-2500    Fax: 952-541-2539

News Archive

Older adults are at greater danger of falling when walking for utilitarian purposes

Older adults are at a greater danger of falling when walking for utilitarian purposes such as shopping and appointments than when walking for recreation, according to a study from UMass Medical School.

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.

Dyadic issued seventh U.S. patent

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").

FDA Advisory Panel recommends approval of Solesta for bowel incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel recommended approval of Solesta™ as a treatment for fecal (bowel) incontinence, a condition afflicting many Americans, primarily women.

Read more Medical News

› Verified 2 days ago